Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome?
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-19
DOI
10.3389/fonc.2020.595838
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
- (2019) David A. Sallman et al. BLOOD
- High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia
- (2018) Ting-juan Zhang et al. GENE
- Myelodysplastic Syndromes
- (2018) Ulrich Germing et al. Deutsches Arzteblatt International
- Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome
- (2017) Yunsuk Choi et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
- (2016) Noemi A. Zambetti et al. Cell Stem Cell
- MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report
- (2016) Antonella Caivano et al. CELLULAR ONCOLOGY
- A miRNA Signature in Human Cord Blood Stem and Progenitor Cells as Potential Biomarker of Specific Acute Myeloid Leukemia Subtypes
- (2015) M. Cattaneo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Circulating microRNAs in aging
- (2015) Massimiliano Bonafè et al. Oncotarget
- MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications
- (2015) Fabiola Olivieri et al. Oncotarget
- Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes
- (2015) Francesco Prattichizzo et al. Clinical Epigenetics
- Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes
- (2014) Yundeok Kim et al. PLoS One
- miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling
- (2013) T. D. Bhagat et al. BLOOD
- Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
- (2013) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating inflamma-miRs in aging and age-related diseases
- (2013) Fabiola Olivieri et al. Frontiers in Genetics
- Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study
- (2012) Esther Natalie Oliva et al. ANNALS OF HEMATOLOGY
- Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
- (2012) B. Will et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging
- (2012) Fabiola Olivieri et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes
- (2011) Lubomir Sokol et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer
- (2011) E. Tili et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)
- (2010) Ji-guang Zhang et al. CLINICA CHIMICA ACTA
- Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia
- (2009) Y. Yamanaka et al. BLOOD
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
- (2008) Y. Jiang et al. BLOOD
- Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With,CEBPAMutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
- (2008) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder
- (2008) Ryan M. O'Connell et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started